Diabetic Neuropathy: Pathogenesis and Treatment. A Review
- 1 March 2004
- journal article
- review article
- Published by Georg Thieme Verlag KG in Journal of Reconstructive Microsurgery
- Vol. 20 (3) , 241-252
- https://doi.org/10.1055/s-2004-823112
Abstract
Neuropathy is a common and devastating complication of diabetes that contributes to mortality in most cases. Multiple factors are thought to play a major role in the pathogenesis of diabetic neuropathy, including alterations in the endoneural metabolism, defective neurotrophic factors, reduced nerve blood supply, and immune mechanisms. Studies of endoneural metabolism and nerve blood-flow alterations have focused on oxidative stress, the polyol pathway, advanced glycation, protein kinase C, and impaired essential fatty acid metabolism. Although many experimental and clinical studies have been performed to determine the most optimal strategy for preventing and treating diabetic neuropathy, tight glycemic control is the mainstay of therapy. In this article, the proposed pathophysiologic mechanisms and therapeutic approaches in diabetic neuropathy are reviewed and discussed with the relevant literature.Keywords
This publication has 31 references indexed in Scilit:
- Effect of Various Nerve Decompression Procedures on the Functions of Distal Limbs in Streptozotocin-Induced Diabetic Rats: Further Optimism in Diabetic NeuropathyPlastic and Reconstructive Surgery, 2003
- Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDPZeitschrift für Neurologie, 2002
- Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectivesDiabetes/Metabolism Research and Reviews, 2002
- An aldose reductase inhibitor reverses early diabetes‐induced changes in peripheral nerve function, metabolism, and antioxidative defenseThe FASEB Journal, 2001
- Taurine Counteracts Oxidative Stress and Nerve Growth Factor Deficit in Early Experimental Diabetic NeuropathyExperimental Neurology, 2001
- Depletion of Taurine in Experimental Diabetic Neuropathy: Implications for Nerve Metabolic, Vascular, and Functional DeficitsExperimental Neurology, 2001
- Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.Diabetes Care, 1999
- The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT)Diabetologia, 1998
- Beneficial Effect of Fetal Islet Grafting on Development of Late Diabetic ComplicationsTransplantation Proceedings, 1998
- AUTOIMMUNE DIABETIC NEUROPATHYNeurologic Clinics, 1997